Clinical Trials Directory

Trials / Conditions / Sinonasal Carcinoma

Sinonasal Carcinoma

10 registered clinical trials studyying Sinonasal Carcinoma — 4 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingA Study of Becotatug Vedotin (MRG003) Combined With Epirubicin as Neoadjuvant Therapy for EGFR-Positive, Unres
NCT07522879
Eye & ENT Hospital of Fudan UniversityPhase 2
RecruitingEpirubicin Interventional Chemotherapy for Sinonasal Adenoid Cystic Carcinoma (SNACC): A Prospective Study
NCT07320508
Eye & ENT Hospital of Fudan UniversityPhase 2
Not Yet RecruitingInduction Chemotherapy and Tazemetostat for Locally Advanced SMARCB1-deficient Sinonasal Carcinoma
NCT05151588
Dr. Victor H.F. LeePhase 2
CompletedHPV in Sinonasal Ca: Retrospective Analysis Association of Human Papilloma Virus (HPV) Serology and Behavioral
NCT04979000
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins—
CompletedExercise Training and Behavioral Modification for the Improvement of Physical Activity in Head and Neck Cancer
NCT04788264
Thomas Jefferson UniversityN/A
RecruitingProspective Sinonasal Cancer Multi-institution Study
NCT04755855
Mayo Clinic—
CompletedPembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinom
NCT03082534
University of California, San DiegoPhase 2
UnknownCell-free Tumor DNA in Head and Neck Cancer Patients
NCT03942380
Christian von BuchwaldN/A
UnknownIntensity-Modulated or Proton Radiation Therapy for Sinonasal Malignancy
NCT01586767
Massachusetts General HospitalN/A
No Longer AvailableTazemetostat Expanded Access Program for Adults With Solid Tumors
NCT03874455
Epizyme, Inc.—